Partner Lee Rosebush is quoted in a July 25, 2023, article titled “FTC’s Message to PBMs Hints at Stricter Regulatory Action, Attorneys Say.”
The National Law Journal piece focuses on the impact on pharmacy benefit managers (PBMs) of recent Federal Trade Commission communications indicating that its current guidelines are outdated, “a move that pharmaceutical lawyers and professors said indicates the agency will take a stricter regulatory stance with PBMs,” according to the article.
“It’s clear that PBMs are in the crosshairs at the moment,” Rosebush told the publication.